This website uses cookies to enhance the user experience.
TA

Terje Arnulf Johansen1955

Shareholdings
6
21
Norway Business roles
17

Roles

Management

NameRoleTotal operating incomeTotal equityShares
F
FDV TROMS AS
Managing Director/CEO
8,256,500
12,757,872
90.1 %
indirectly
L
LYR INVEST AS
Managing Director/CEO
-
180,209,677
90.1 %
directly
T
TAJ EIENDOM AS
Managing Director/CEO
-
1,006,939
90.1 %
indirectly
B
BOLIGUTVIKLING SØR AS
Managing Director/CEO
225,500
490,397
90.1 %
indirectly
T
TAJ HOLDING AS
Managing Director/CEO
75,072,912
179,647,693
90.1 %
indirectly
A
ARELIA AS
Managing Director/CEO
-
1,236
72.08 %
indirectly

Boards

NameRoleTotal operating incomeTotal equityShares
C
CAMPUS NORGE AS
Chairman
1,943,520
1,503,461
90.1 %
indirectly
F
FDV TROMS AS
Chairman
8,256,500
12,757,872
90.1 %
indirectly
L
LYR INVEST AS
Chairman
-
180,209,677
90.1 %
directly
T
TAJ EIENDOM AS
Chairman
-
1,006,939
90.1 %
indirectly
B
BOLIGUTVIKLING SØR AS
Chairman
225,500
490,397
90.1 %
indirectly
T
TAJ HOLDING AS
Chairman
75,072,912
179,647,693
90.1 %
indirectly
T
TJ EIENDOM AS
Chairman
-
12,365,088
85.6 %
indirectly
A
ARELIA AS
Chairman
-
1,236
72.08 %
indirectly
A
ANS BYGG I NORD
Participant with Joint and Several Liability (Full Responsibility)
-
-
-
Last update: Dec 31, 2024

Related industries4

Direct relationships5

Shares owned by Terje Arnulf Johansen

NameShare classTotal operating incomeTotal equityShare
P
PGS ASA
NO0010199151
0
6,420,000,000
0.1 %
directly < 0.01 %
A
AKER ASA
NO0010234552
0
23,669,000,000
< 0.01 %
directly
L
LYR INVEST AS
A-aksjer
B-aksjer
0
0
180,209,677
180,209,677
45.05 %
directly 90.1 %
45.05 %
directly 90.1 %
C
CAMPUS NORGE AS
1,943,520
1,503,461
90.1 %
indirectly
F
FDV TROMS AS
8,256,500
12,757,872
90.1 %
indirectly
T
TAJ EIENDOM AS
0
1,006,939
90.1 %
indirectly
B
BOLIGUTVIKLING SØR AS
225,500
490,397
90.1 %
indirectly
T
TAJ HOLDING AS
75,072,912
179,647,693
90.1 %
indirectly
T
TJ EIENDOM AS
0
12,365,088
85.6 %
indirectly
A
ARELIA AS
0
1,236
72.08 %
indirectly
N
NORSK EIENDOM OG UTVIKLING AS
15,000
1,718,733
27.03 %
indirectly
A
AMICOAT AS
17,688,664
55,955,218
10.47 %
indirectly
P
PEPTIDE PATENTS AS
1,081,801
654,242
10.47 %
indirectly
P
PHARMA HOLDINGS AS
1,740,889
16,353,280
10.47 %
indirectly
L
LYSAKER PARK INVEST I AS
356,604
9,716,304
7.66 %
indirectly
L
LYSAKER PARK INVEST II AS
0
152,468,744
6.36 %
indirectly
N
NORTH ENERGY ASA
72,000
368,737,000
1.42 %
indirectly
N
NORTH INDUSTRIES 2 AS
0
68,327,565
1.42 %
indirectly
N
NORTH INDUSTRIES 1 AS
0
179,876,205
1.42 %
indirectly
P
PHARMASUM THERAPEUTICS AS
1,379,500
2,785,322
1.3 %
indirectly
O
OBSERVE MEDICAL ASA
2,591,000
355,305,000
1.09 %
indirectly
O
OBSERVE MEDICAL AS
0
-440,466
1.09 %
indirectly
B
BIIM ULTRASOUND AS
4,069,953
-29,193,114
1.09 %
indirectly
T
TYVEHOLMEN AS
6,409,335
8,995,135
0.71 %
indirectly
L
LYTIX BIOPHARMA AS
NO0010405780
3,991,213
51,319,307
0.12 %
directly 0.12 %
indirectly 9.11 %
T
TGS ASA
NO0003078800
160,588,000
207,091,000
0.05 %
directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025